Dr. Fazio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3303 S Bond Ave
Portland, OR 97239Phone+1 503-418-9008
Education & Training
- Sapienza University of RomeClass of 1983
Certifications & Licensure
- OR State Medical License 2016 - 2020
- TN State Medical License 1994 - 2014
Awards, Honors, & Recognition
- Board of Directors American Board of Clinical Lipidology, 2015
- Elected Member Association of American Physicians, 2011
- Elected Member American Society for Clinical Investigation, 2001
Publications & Presentations
PubMed
- 413 citationsDisruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice.Tillmann Cyrus, Joseph L. Witztum, Daniel J. Rader, Rajendra K. Tangirala, Sergio Fazio
The Journal of Clinical Investigation. 1999-06-01 - 37 citationsNonpharmacologic Treatment of DyslipidemiaMark C. Houston, Sergio Fazio, Floyd H. Chilton, Dan E. Wise, Kathryn B. Jones
Progress in Cardiovascular Diseases. 2009-09-01 - 26 citationsMacrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.Hagai Tavori, Yan Ru Su, Patricia G. Yancey, Ilaria Giunzioni, Ashley J. Wilhelm
Journal of Lipid Research. 2015-03-01
Journal Articles
- The Present and Future JACC State-of-the-Art Review the Evolving Future of PCSK9 InhibitorsRobert S Rosenson, Sergio Fazio, ScienceDirect
- Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL CholesterolSephy Philip, Sergio Fazio, The Journal of Clinical Endocrinology and Metabolism
- Effects of 12 Weeks of Treatment with Intravenously Administered Bococizumab, a Humanized Monoclonal Antibody Blocking Proprotein Convertase subtilisin/kexin Type 9, i...Charles M Baum, Sergio Fazio, Cardiovascular Therapeutics
Lectures
- Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 InhibitorENDO 2019 - New Orleans, LA - 3/25/2019
- Cholesterol-Carrying Lipoproteins and Cardiovascular Risk: New Guidelines and BeyondENDO 2019 - New Orleans, LA - 3/24/2019
- Familial Lipid Disorders: What Every Lipid-Savvy Endocrinologist Needs to KnowENDO 2019 - New Orleans, LA - 3/23/2019
- Join now to see all
Press Mentions
- Erin Michos, MD, MHS, FASPC Is Named Co Editor-in-Chief of the American Journal of Preventive CardiologyFebruary 17th, 2021
- AACE/ACE Consensus Statement Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive SummaryDecember 28th, 2020
- ASPC Launches New Journal Focused on Preventive CardiologyMarch 27th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: